ISRCTN54728875已完成未知
A randomised trial of CF (infusional 5-fluorouracil and cisplatin) alone versus CF plus concurrent radiotherapy in patients with locally advanced pancreatic carcinoma
The Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histological evidence of locally advanced or unresectable pancreatic adenocarcinoma
- •2. Patients evaluable for response must have bidmensionally measurable disease as assessed by Computed Tomography (CT) scans
- •3. No prior chemotherapy or radiotherapy
- •4. Life expectancy of >3 months
- •5. Adequate bone marrow and renal function
- •6. World Health Organisation (WHO) performance status 0-2 at randomisation
- •7. No medical contraindications to treatment protocols
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
A randomised trial of infusional 5-fluorouracil and concomitant radiotherapy in locally advanced rectal cancer, comparing three and six months of infusional 5-fluorouracilCancer of rectumCancerISRCTN93845533The Royal Marsden NHS Foundation Trust (UK)
已完成
不适用
A randomised study of continuous infusional 5-fluorouracil (5FU) with or without bolus mitomycin-C in patients with advanced oesophago-gastric cancerAdvanced oesophago-gastric cancerMalignant neoplasm of stomachCancerISRCTN43866427The Royal Marsden NHS Foundation Trust (UK)254
已完成
不适用
A randomised study of continuous infusional 5-fluorouracil with or without bolus mitomycin-C in patients with advanced colorectal cancerColon, Rectal cancerMalignant neoplasm of other and ill-defined digestive organsCancerISRCTN27478455The Royal Marsden NHS Foundation Trust (UK)200
进行中（未招募）
不适用
A randomised clinical trial of treatment for fluorouracil-resistant advanced colorectal cancer comparing standard single-agent irinotecan versus irinotecan plus panitumumab and versus irinotecan plus ciclosporin - PICCOLO: Panitumumab, Irinotecan & Ciclosporin in Colorectal cancer therapyEUCTR2005-003492-20-GBniversity of Leeds1,324
已完成
不适用
A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without bolus mitomycin-C in patients with carcinoma of unknown primary origiCarcinoma of unknown primary originMalignant neoplasm without specification of siteCancerISRCTN63374575The Royal Marsden NHS Foundation Trust (UK)88